ManishBhandariMD

Oncology • Edgewood, KY

Physician

Join to view full profile

Dr. Bhandari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhandari's full profile

Already have an account?

Office
1 Medical Village Dr
Edgewood, KY 41017
Phone+1 859-301-4000

Fax+1 859-301-4001

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2003 - 2005
Brown UniversityInternship, Internal Medicine, 1996 - 1997
Harvard Medical SchoolClass of 1996

Certifications & Licensure

CA State Medical License 2001 - Present
KY State Medical License 2005 - 2025
OH State Medical License 2005 - 2025
MI State Medical License 2003 - 2005
American Board of Internal Medicine Medical Oncology

Clinical Trials

Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer Start of enrollment: 2010 Mar 01
Terminated
Phase 2
A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers
No longer available

Publications & Presentations

PubMed

3 citations
Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes.
Riley G Jones, Felix Karthik, Anushree Dugar, Karthik Kanagarajan, Kalpan Desai
The American Journal of Case Reports. 2018-07-04
20 citations
Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme
Menal Bhandari, Ajeet Kumar Gandhi, Bharti Devnani, Pavnesh Kumar, Daya Nand Sharma
Journal of Clinical and Diagnostic Research. 2017-05-01
7 citations
Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma
Manish S. Bhandari, Kenneth J. Pienta, Judith Fardig, Karin B. Olson, David Smith
Cancer. 2006-04-15

Journal Articles

Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes
Manish Bhandari, Kalpan Desai, The American Journal of Case Reports

Press Mentions

Leading Medical Oncologist, Dr. Manish Bhandari, Joins St. Elizabeth Healthcare; Leads Clinical TrialsJanuary 26th, 2022
S4 Medical Closes Series A FinancingApril 2nd, 2021
Heart Valve Innovator Foldax Closes $20 Million FinancingJune 22nd, 2020